Bacilli Calmette-Guerin (BCG) is the only vaccine approved worldwide for clinical use to prevent TB, but it fails to induce enough M.tb-specific CD8+ T cells and elicit optimal immune memory in the lung (Beverley et al., 2014). The gene discussed is CD8A; the disease is tuberculosis.